February 7, 2018 / 7:44 AM / 5 months ago

BRIEF-Follicum: Phase IIa Study Approved By German Authority

Feb 7 (Reuters) - FOLLICUM AB:

* FOLLICUM PHASE IIA STUDY OF FOL-005 AGAINST HAIR LOSS APPROVED BY THE GERMAN MEDICINES AGENCY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below